Nicotine addiction causes unique detrimental effects on women's brains

Journal of Addictive Diseases

Volumn 30, Issue 2, 2011, Pages 149-158

  Raval, Ami P ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Aromatase; birth control pills; cerebral ischemia; estrogen; estrogen receptors; stroke

Indexed keywords

ALDEHYDE OXIDASE; AROMATASE; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; COTININE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOCHROME P450; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; KAINIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINE; ORAL CONTRACEPTIVE AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; SEX HORMONE;

AGGRESSION; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ASTROCYTE; AUTISM; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CIGARETTE SMOKING; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG METABOLISM; EARLY MENOPAUSE; ENDOTHELIUM CELL; ENZYME METABOLISM; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; ESTRUS CYCLE; HALF LIFE TIME; HEALTH SURVEY; HORMONE BLOOD LEVEL; HORMONE INHIBITION; HUMAN; HUNTINGTON CHOREA; HYPOGLYCEMIA; HYPOXIA; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LEUKOCYTE AGGREGATION; LIPID METABOLISM; MEDICAL LITERATURE; MENSTRUAL IRREGULARITY; METABOLITE; MOOD; MOOD DISORDER; MULTIPLE SCLEROSIS; NEUROPHYSIOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RISK; SCHIZOPHRENIA; SEX DIFFERENCE; SEXUAL BEHAVIOR; SIGNAL TRANSDUCTION; STROKE; THROMBOGENESIS; TOBACCO DEPENDENCE; TRAUMATIC BRAIN INJURY;

BRAIN; CARDIOVASCULAR DISEASES; ESTROGENS; FEMALE; HUMANS; MALE; NICOTINE; RECEPTORS, NICOTINIC; RISK FACTORS; SEX FACTORS; TOBACCO USE DISORDER;

EID: 79957470750     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2011.554782     Document Type: Conference Paper

References (107)

1. Benowitz NL. Clinical pharmacology of nicotine. Ann Rev Med 1986; 37:21-32.
2. Osler M, Prescott E, Godtfredsen N, Hein HO, Schnohr P. Gender and determinants of smoking cessation: a longitudinal study. Prev Med 1999; 29:57-62. (Pubitemid 29370298)
3. Prescott E, OslerM, Andersen PK, Hein HO, Borch- Johnsen K, Lange P, Schnohr P, Vestbo J. Mortality in women and men in relation to smoking. Int J Epidemiol 1998; 27:27-32. (Pubitemid 28140499)
4. Orlandi MA. Gender differences in smoking cessation. Women Health 1986; 11:237-51.
5. Can G, Oztuna F, Topbas M. Complaints related to smoking cessation. Tuberk Toraks 2007; 55:364-9. (Pubitemid 350225544)
6. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie- Rosett J, Roger VL, Turner MB. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation; 123(4):e18-e209.
7. Hoffmann D, Hoffmann I, El-Bayoumy K. The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol 2001; 14:767-90.
8. Rodgman A, Smith CJ, Perfetti TA. The composition of cigarette smoke: a retrospective, with emphasis on polycyclic components. Hum Exp Toxicol 2000; 19:573-95. (Pubitemid 32117869)
9. Borgerding M, Klus H. Analysis of complex mixtures: cigarette smoke. Exp Toxicol Pathol 2005; 57(Suppl 1):43-73. (Pubitemid 40884483)
10. Wang H, Shi H, Wang Z. Nicotine depresses the functions of multiple cardiac potassium channels. Life Sci 1999; 65:PL143-9. (Pubitemid 29425971)
11. Keeley EC, Pirwitz MJ, Landau C, Lange RA, Hillis LD, Foerster EH, Conrad K,Willard JE. Intranasal nicotine spray does not augment the adverse effects of cigarette smoking on myocardial oxygen demand or coronary arterial dimensions. Am J Med 1996; 101:357-63. (Pubitemid 26392852)
12. Hukkanen J, Jacob P 3rd, Benowitz NL.Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005; 57:79-115. (Pubitemid 40283970)
13. Gritz ER, Baer-Weiss V, Benowitz NL, Van Vunakis H, Jarvik ME. Plasma nicotine and cotinine concentrations in habitual smokeless tobacco users. Clin Pharmacol Ther 1981; 30:201-9. (Pubitemid 11039358)
14. Cashman JR, Park SB, Yang ZC, Wrighton SA, Jacob P 3rd, Benowitz NL. Metabolism of nicotine by human liver microsomes: stereoselective formation of transnicotine n'-oxide. Chem Res Toxicol 1992; 5:639-46.
15. Mwenifumbo JC, Tyndale RF.Molecular genetics of nicotine metabolism. Handb Exp Pharmacol 2009:235-59.
16. von Weymarn LB, Brown KM, Murphy SE. Inactivation of cyp2a6 and cyp2a13 during nicotine metabolism. J Pharmacol Exp Ther 2006; 316:295-303. (Pubitemid 41832609)
17. Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P 3rd. Female sex and oral contraceptive use accelerate nicotinemetabolism. Clin Pharmacol Ther 2006; 79:480-8.
18. Berlin I, Gasior MJ, Moolchan ET. Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers. Nicotine Tob Res 2007; 9:493-8. (Pubitemid 46534461)
19. Abbruscato TJ, Lopez SP, Mark KS, Hawkins BT, Davis TP. Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of zo- 1 through nicotinic acetylcholine receptors expressed on brain endothelial cells. J Pharm Sci 2002; 91:2525-38. (Pubitemid 35379411)
20. Hawkins BT, Abbruscato TJ, Egleton RD, Brown RC, Huber JD, Campos CR, Davis TP. Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res 2004; 1027:48-58. (Pubitemid 39370994)
21. Hioki H, Aoki N, Kawano K, Homori M, Hasumura Y, Yasumura T,Maki A, Yoshino H, Yanagisawa A, Ishikawa K. Acute effects of cigarette smoking on plateletdependent thrombin generation. Eur Heart J 2001; 22:56-61. (Pubitemid 32622189)
22. Lilienberg G, Venge P. Platelet adhesion in patients prone to arterial and venous thrombosis: the impact of gender, smoking and heredity. Scand J Clin Lab Invest 1998; 58:279-86. (Pubitemid 28396215)
23. Lindenblatt N, Platz U, Hameister J, Klar E, Menger MD, Vollmar B. Distinct effects of acute and chronic nicotine application on microvascular thrombus formation and endothelial function inmale and female mice. Langenbecks Arch Surg 2007; 392:285-295. (Pubitemid 46675808)
24. Powell JT. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med 1998; 3:21-8. (Pubitemid 28267456)
25. Rahman MM, Laher I. Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Pharmacol 2007; 5:276-92.
26. Ikonomidis I, Lekakis J, Vamvakou G, Andreotti F, Nihoyannopoulos P. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. Am Heart J 2005; 149:832-9. (Pubitemid 40718878)
27. Booyse FM, Osikowicz G, Quarfoot AJ. Effects of chronic oral consumption of nicotine on the rabbit aortic endothelium. Am J Pathol 1981; 102:229-38. (Pubitemid 12190462)
28. Cassidenti DL, Vijod AG, Vijod MA, Stanczyk FZ, Lobo RA. Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women. Am J Obstet Gynecol 1990; 163:1953-60.
29. Cramer DW, Harlow BL, Xu H, Fraer C, Barbieri R. Cross-sectional and case-controlled analyses of the association between smoking and early menopause. Maturitas 1995; 22:79-87.
30. Damaj MI. Influence of gender and sex hormones on nicotine acute pharmacological effects inmice. J Pharmacol Exp Ther 2001; 296:132-40. (Pubitemid 32015071)
31. Grainge MJ, Coupland CA, Cliffe SJ, Chilvers CE, Hosking DJ. Cigarette smoking, alcohol and caffeine consumption, and bone mineral density in postmenopausal women: the Nottingham Epic Study Group. Osteoporos Int 1998; 8:355-63. (Pubitemid 28418270)
32. Greenberg G, Thompson SG, Meade TW. Relation between cigarette smoking and use of hormonal replacement therapy for menopausal symptoms. J Epidemiol Community Health 1987; 41:26-9. (Pubitemid 17017743)
33. Jensen J, Christiansen C, Rodbro P. Cigarette smoking, serum estrogens, and bone loss during hormonereplacement therapy early after menopause. N Engl J Med 1985; 313:973-5. (Pubitemid 15250216)
34. Michnovicz JJ, Naganuma H, Hershcopf RJ, Bradlow HL, Fishman J. Increased urinary catechol estrogen excretion in female smokers. Steroids 1988; 52:69-83. (Pubitemid 19060420)
35. Mueck AO, Seeger H. Smoking, estradiol metabolism and hormone replacement therapy. Curr Med Chem Cardiovasc Hematol Agents 2005; 3:45-54. (Pubitemid 40057730)
36. Windham GC, Elkin EP, Swan SH,Waller KO, Fenster L. Cigarette smoking and effects onmenstrual function. Obstet Gynecol 1999; 93:59-65.
37. Baillargeon JP, McClish DK, Essah PA, Nestler JE. Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a metaanalysis. J Clin Endocrinol Metab 2005; 90:3863-70. (Pubitemid 41058144)
38. Escobedo LG, Caspersen CJ. Risk factors for sudden coronary death in the United States. Epidemiology 1997; 8:175-180. (Pubitemid 27084189)
39. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL. Primary prevention of ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council: cosponsored by the atherosclerotic peripheral vascular disease interdisciplinary working group; cardiovascular nursing council; clinical cardiology council; nutrition, physical activity, and metabolism council; and the quality of care and outcomes research interdisciplinary working group. Circulation 2006; 113:e873-923. (Pubitemid 44313581)
40. Tanis BC, van den Bosch MA, Kemmeren JM, Cats VM, Helmerhorst FM,Algra A, van der GraafY, Rosendaal FR. Oral contraceptives and the risk of myocardial infarction. N Engl J Med 2001; 345:1787-93.
41. Girolami A, Tezza F, Allemand E, Girolami B. Arterial thrombosis and drospirenone-containing pill (yasmin): is the pill to be absolutely avoided by women who smoke? J Thromb Thrombolysis 2008; 26:163-4.
42. Roselli CE, Horton LE, Resko JA. Distribution and regulation of aromatase activity in the rat hypothalamus and limbic system. Endocrinology 1985; 117:2471-7. (Pubitemid 16194078)
43. Rune GM, Frotscher M. Neurosteroid synthesis in the hippocampus: role in synaptic plasticity. Neuroscience 2005; 136:833-42. (Pubitemid 41774728)
44. Ryan KJ, Naftolin F, Reddy V, Flores F, Petro Z. Estrogen formation in the brain.AmJObstetGynecol 1972; 114:454-60.
45. Azcoitia I, Sierra A, Veiga S, Garcia-Segura LM. Aromatase expression by reactive astroglia is neuroprotective. Ann N Y Acad Sci 2003; 1007:298-305. (Pubitemid 38253675)
46. LiuM,Oyarzabal EA,YangR,Murphy SJ, Hurn PD. A novel method for assessing sex-specific and genotypespecific response to injury in astrocyte culture. J Neurosci Methods 2008; 171:214-7.
47. Liu M, Hurn PD, Roselli CE, Alkayed NJ. Role of p450 aromatase in sex-specific astrocytic cell death. JCereb Blood Flow Metab 2007; 27:135-41. (Pubitemid 46006591)
48. Prange-Kiel J, Wehrenberg U, Jarry H, Rune GM. Para/autocrine regulation of estrogen receptors in hippocampal neurons. Hippocampus 2003; 13:226-34. (Pubitemid 36503535)
49. Hojo Y, Hattori TA, Enami T, Furukawa A, Suzuki K, Ishii HT, Mukai H, Morrison JH, Janssen WG, Kominami S, Harada N, Kimoto T, Kawato S. Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes p45017alpha and p450 aromatase localized in neurons. Proc Natl Acad Sci U S A 2004; 101:865-70. (Pubitemid 38121049)
50. Azcoitia I, Sierra A, Veiga S, Honda S, Harada N, Garcia-Segura LM. Brain aromatase is neuroprotective. J Neurobiol 2001; 47:318-29. (Pubitemid 32467339)
51. Garcia-Segura LM, Veiga S, Sierra A, Melcangi RC, Azcoitia I. Aromatase: a neuroprotective enzyme. Prog Neurobiol 2003; 71:31-41. (Pubitemid 37377933)
52. McCullough LD, Blizzard K, Simpson ER, Oz OK, Hurn PD. Aromatase cytochrome p450 and extragonadal estrogen play a role in ischemic neuroprotection. J Neurosci 2003; 23:8701-5. (Pubitemid 37176650)
53. Roselli CE, Liu M, Hurn PD. Brain aromatization: classic roles and new perspectives. Semin Reprod Med 2009; 27:207-17.
54. Saldanha CJ, Duncan KA, Walters BJ. Neuroprotective actions of brain aromatase. Front Neuroendocrinol 2009; 30:106-18.
55. Barbieri RL, Gochberg J, Ryan KJ. Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro. J Clin Invest 1986; 77:1727-33. (Pubitemid 16062622)
56. Biegon A, Kim SW, Logan J, Hooker JM, Muench L, Fowler JS. Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons. Biol Psychiatry 2010; 67:774-7.
57. Roselli CE, Resko JA. Cytochrome p450 aromatase (cyp19) in the non-human primate brain: distribution, regulation, and functional significance. J Steroid Biochem Mol Biol 2001; 79:247-53. (Pubitemid 34158801)
58. Cosimo Melcangi R, Garcia-Segura LM. Sexspecific therapeutic strategies based on neuroactive steroids: in search for innovative tools for neuroprotection. Horm Behav 2010; 57:2-11.
59. Gillies GE, McArthur S. Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev 2010; 62:155-98.
60. Dulac C. Brain function and chromatin plasticity. Nature 2010; 465:728-35.
61. Xu J, Watkins R, Arnold AP. Sexually dimorphic expression of the x-linked gene eif2s3x mrna but not protein in mouse brain. Gene Expr Patterns 2006; 6:146-55. (Pubitemid 43071909)
62. Reisert I, Pilgrim C. Sexual differentiation of monoaminergic neurons: genetic or epigenetic? Trends Neurosci 1991; 14:468-73.
63. Gagnidze K, Pfaff DW. Sex on the brain. Cell 2009; 139:19-21.
64. Bramlett HM. Sex differences and the effect of hormonal therapy on ischemic brain injury. Pathophysiology 2005; 12:17-27. (Pubitemid 40779442)
65. Roof RL, Hall ED. Gender differences in acute cns trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma 2000; 17:367-88. (Pubitemid 30327300)
66. Zhang YQ, Shi J, Rajakumar G, Day AL, Simpkins JW. Effects of gender and estradiol treatment on focal brain ischemia. Brain Res 1998; 784:321-4. (Pubitemid 28137875)
67. Li R, ShenY. Estrogen and brain: synthesis, function and diseases. Front Biosci 2005; 10:257-67. (Pubitemid 40543032)
68. McCullough LD, Hurn PD. Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrinol Metab 2003; 14:228-35. (Pubitemid 36841481)
69. Rusa R, AlkayedNJ, Crain BJ, Traystman RJ, Kimes AS, London ED, Klaus JA, Hurn PD. 17beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke 1999; 30:1665-70. (Pubitemid 29379621)
70. Pelligrino DA, Santizo R, Baughman VL, Wang Q. Cerebral vasodilating capacity during forebrain ischemia: effects of chronic estrogen depletion and repletion and the role of neuronal nitric oxide synthase. Neuroreport 1998; 9:3285-91. (Pubitemid 28522350)
71. Jover T, Tanaka H, Calderone A, Oguro K, Bennett MV, Etgen AM, Zukin RS. Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal ca1. J Neurosci 2002; 22:2115-24. (Pubitemid 35390362)
72. Lebesgue D, Chevaleyre V, Zukin RS, Etgen AM. Estradiol rescues neurons from global ischemia-induced cell death: multiple cellular pathways of neuroprotection. Steroids 2009; 74:555-61.
73. Lebesgue D, Traub M, De Butte-Smith M, Chen C, Zukin RS, Kelly MJ, Etgen AM. Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats. PLoS One5:e8642.
74. Azcoitia I, Fernandez-Galaz C, Sierra A, Garcia- Segura LM. Gonadal hormones affect neuronal vulnerability to excitotoxin-induced degeneration. J Neurocytol 1999; 28:699-710.
75. Raval AP, Saul I, Dave KR, DeFazio RA, Perez- Pinzon MA, Bramlett H. Pretreatment with a single estradiol-17beta bolus activates cyclic-amp response element binding protein and protects ca1 neurons againstglobal cerebral ischemia. Neuroscience 2009; 160:307-18.
76. Raval AP, Bhatt A, Saul I. Chronic nicotine exposure inhibits 17beta-estradiol-mediated protection of the hippocampal ca1 region against cerebral ischemia in female rats. Neurosci Lett 2009; 458:65-69.
77. Prokai L, Prokai-Tatrai K, Perjesi P, Zharikova AD, Perez EJ, Liu R, Simpkins JW. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc Natl Acad Sci U S A 2003; 100:11741-6. (Pubitemid 37206005)
78. Kumar S, Lata K, Mukhopadhyay S, Mukherjee TK. Role of estrogen receptors in pro-oxidative and antioxidative actions of estrogens: a perspective. Biochim Biophys Acta 2010; 1800(10): 1127-35.
79. Sribnick EA, Ray SK, Banik NL. Estrogen as a multi-active neuroprotective agent in traumatic injuries. Neurochem Res 2004; 29:2007-14. (Pubitemid 39663879)
80. Weaver CE Jr, Park-Chung M, Gibbs TT, Farb DH. 17beta-estradiol protects against nmda-induced excitotoxicity by direct inhibition of nmda receptors. Brain Res 1997; 761:338-41. (Pubitemid 27305996)
81. Wojtowicz T, Mozrzymas JW. Estradiol and gabaergic transmission in the hippocampus. Vitam Horm 82:279-300.
82. Ma XM, Huang JP, Kim EJ, Zhu Q, Kuchel GA, Mains RE, Eipper BA. Kalirin-7, an important component of excitatory synapses, is regulated by estradiol in hippocampal neurons. Hippocampus 2010 (in press).
83. Dubal DB, Shughrue PJ,WilsonME, Merchenthaler I,Wise PM. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci 1999; 19:6385-93. (Pubitemid 29347438)
84. Alkayed NJ, Goto S, Sugo N, Joh HD, Klaus J, Crain BJ, Bernard O, Traystman RJ, Hurn PD. Estrogen and bcl- 2: gene induction and effect of transgene in experimental stroke. J Neurosci 2001; 21:7543-50. (Pubitemid 32904953)
85. Jover-Mengual T, Zukin RS, Etgen AM. Mapk signaling is critical to estradiol protection of ca1 neurons in global ischemia. Endocrinology 2007; 148:1131-43.
86. Wade CB, Dorsa DM. Estrogen activation of cyclic adenosine 5'-monophosphate response elementmediated transcription requires the extracellularly regulated kinase/mitogen-activated protein kinase pathway. Endocrinology 2003; 144:832-8. (Pubitemid 36262850)
87. Lee SJ, Campomanes CR, Sikat PT, Greenfield AT, Allen PB, McEwen BS. Estrogen induces phosphorylation of cyclic amp response element binding (pcreb) in primary hippocampal cells in a time-dependent manner. Neuroscience 2004; 124:549-60. (Pubitemid 38251323)
88. Wu TW, Wang JM, Chen S, Brinton RD. 17betaestradiol induced ca2+ influx via l-type calcium channels activates the src/erk/cyclic-amp response element binding protein signal pathway and bcl-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced neuroprotection. Neuroscience 2005; 135:59-72. (Pubitemid 41219738)
89. Sarkar SN, Huang RQ, Logan SM, Yi KD, Dillon GH, Simpkins JW. Estrogens directly potentiate neuronal l-type ca2+ channels. Proc Natl Acad Sci U S A 2008; 105:15148-53.
90. Dolmetsch RE, Pajvani U, Fife K, Spotts JM, Greenberg ME. Signaling to the nucleus by an l-type calcium channel-calmodulin complex through the map kinase pathway. Science 2001; 294:333-9. (Pubitemid 32963394)
91. Vaillant AR, Mazzoni I, Tudan C, Boudreau M, Kaplan DR,Miller FD. Depolarization and neurotrophins converge on the phosphatidylinositol 3-kinase-akt pathway to synergistically regulate neuronal survival. J Cell Biol 1999;146:955-66. (Pubitemid 29430439)
92. Raval AP, Bramlett H, Perez-Pinzon MA. Estrogen preconditioning protects the hippocampal ca1 against ischemia. Neuroscience 2006; 141:1721-30. (Pubitemid 44233129)
93. Toran-Allerand CD. Estrogen and the brain: beyond er-alpha and er-beta. Exp Gerontol 2004; 39:1579-86. (Pubitemid 39576128)
94. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Treuter E, Warner M, Gustafsson JA. Estrogen receptors: how do they signal and what are their targets. PhysiolRev 2007; 87:905-31. (Pubitemid 47084672)
95. Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen receptor beta: an overview and update. Nucl Recept Signal 2008; 6:e003.
96. Liu F, Day M, Muniz LC, Bitran D, Arias R, Revilla- Sanchez R, Grauer S, Zhang G, Kelley C, Pulito V, Sung A, Mervis RF, Navarra R, HirstWD, Reinhart PH,Marquis KL,Moss SJ, Pangalos MN, Brandon NJ. Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci 2008; 11:334-43. (Pubitemid 351311804)
97. RavalAP, Hirsch N, Dave KR,Yavagal DR,Bramlett H, Saul I. Nicotine and estrogen synergistically exacerbate cerebral ischemic injury. Neuroscience 2011; In press.
98. Noppens RR, Kofler J, Grafe MR, Hurn PD, Traystman RJ. Estradiol after cardiac arrest and cardiopulmonary resuscitation is neuroprotective and mediated through estrogen receptor-beta. J Cereb Blood Flow Metab 2009; 29:277-86.
99. Zhang QG, Raz L, Wang R, Han D, De Sevilla L, Yang F, Vadlamudi RK, Brann DW. Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of nadph oxidase activation. J Neurosci 2009; 29:13823-36.
100. DubalDB, Rau SW, Shughrue PJ, Zhu H,Yu J, Cashion AB, Suzuki S, Gerhold LM, Bottner MB, Dubal SB, Merchanthaler I, Kindy MS, Wise PM. Differential modulation of estrogen receptors (ers) in ischemic brain injury: a role for eralpha in estradiol-mediated protection against delayed cell death. Endocrinology 2006; 147:3076-84. (Pubitemid 43764643)
101. Ardelt AA, McCullough LD, Korach KS, Wang MM, Munzenmaier DH, Hurn PD. Estradiol regulates angiopoietin-1 mrna expression through estrogen receptoralpha in a rodent experimental stroke model. Stroke 2005; 36:337-41. (Pubitemid 40170819)
102. Jesmin S, Hattori Y, Sakuma I, Liu MY, Mowa CN, Kitabatake A. Estrogen deprivation and replacement modulate cerebral capillary density with vascular expression of angiogenic molecules in middle-aged female rats. J Cereb Blood Flow Metab 2003; 23:181-9. (Pubitemid 36188456)
103. Krause DN, Duckles SP, Pelligrino DA. Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol 2006; 101:1252-61. (Pubitemid 44497571)
104. Turtzo LC, McCullough LD. Sex differences in stroke. Cerebrovasc Dis 2008; 26:462-74.
105. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev 2008; 60:210-41. (Pubitemid 351962010)
106. Guo J, Krause DN, Horne J, Weiss JH, Li X, Duckles SP. Estrogen-receptor-mediated protection of cerebral endothelial cell viability and mitochondrial function after ischemic insult in vitro. J Cereb Blood Flow Metab 2010; 30:545-54.
107. Bake S, Ma L, Sohrabji F. Estrogen receptor-alpha overexpression suppresses 17beta-estradiol-mediated vascular endothelial growth factor expression and activation of survival kinases. Endocrinology 2008; 149: 3881-9.